Senate Finance leaders in talks on deal to limit drug price increases

Ref: The Hill
  • According to sources familiar with the negotiations, leaders of the US Senate Finance Committee are holding bipartisan discussions on a potential deal to limit drug price increases in Medicare, reported The Hill.

  • One proposal is to require that drugmakers pay back rebates to Medicare's Part D prescription drug program if their prices rise faster than inflation.

  • Another measure would force pharmaceutical firms to pay money back to Medicare if they launch a new drug with a high price.

  • However, some lawmakers are pushing back on the idea, arguing it comes too close to price controls for drugs, which Republicans have long opposed, the news source said.